Authors:
Moore, JE
Buckley, TC
Millar, BC
Gibson, P
Cannon, G
Egan, C
Cosgrove, H
Stanbridge, S
Anzai, T
Matsuda, M
Murphy, PG
Citation: Je. Moore et al., Molecular surveillance of the incidence of Taylorella equigenitalis and Pseudomonas aeruginosa from horses in Ireland by sequence-specific PCR [SS-PCR], EQUINE V J, 33(3), 2001, pp. 319-322
Authors:
Egan, C
Grinde, E
Dupre, A
Roth, BL
Hake, M
Teitler, M
Herrick-Davis, K
Citation: C. Egan et al., Agonist high and low affinity state ratios predict drug intrinsic activityand a revised ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptors, SYNAPSE, 35(2), 2000, pp. 144-150
Authors:
Glennon, RA
Dukat, M
Grella, B
Hong, SS
Costantino, L
Teitler, M
Smith, C
Egan, C
Davis, K
Mattson, MV
Citation: Ra. Glennon et al., Binding of beta-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D-2) and benzodiazepine receptors, DRUG AL DEP, 60(2), 2000, pp. 121-132
Authors:
Egan, C
Pang, A
Durda, D
Cheng, HC
Wang, JH
Fujita, DJ
Citation: C. Egan et al., Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530, ONCOGENE, 18(5), 1999, pp. 1227-1237
Authors:
Berguer, R
Bravo, CN
Bowyer, M
Egan, C
Knolmayer, T
Ferrick, D
Citation: R. Berguer et al., Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release of helper T-cell type 2 cytokines, ARCH SURG, 134(5), 1999, pp. 540-544
Authors:
Lee, M
Kemp, JA
Canning, A
Egan, C
Tataronis, G
Farraye, FA
Citation: M. Lee et al., A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy, ARCH IN MED, 159(19), 1999, pp. 2312-2316